Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUAI.L Regulatory News (UAI)

  • There is currently no data for UAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IMS for period from 1st September 2013 to date

16 Jan 2014 07:22

RNS Number : 8048X
Development Securities PLC
16 January 2014
 



16th January 2014

Development Securities PLC ("Development Securities" or "The Company") - Interim Management Statement for the period from 1st September 2013 to date

Development Securities today announces its Interim Management Statement for the period from 1st September 2013 to date.

Commenting on the Company's activities, Michael Marx, Chief Executive Officer, said:

"We continue to make good progress to realise value across our diversified portfolio of assets. Our track record for delivering development and trading gains is established and we are set to realise further significant profits through asset realisations this year and in the years to come. With the economy showing continued signs of recovery, and confidence and activity levels rising outside of the Central London property markets, we also see further opportunities to invest in assets where we can create value through regeneration. The Company is well positioned to continue to deliver on its stated strategy, with a strong balance sheet and a healthy pipeline of projects established. "

Development and trading portfolio

We have continued to make good progress to underwrite further gains across our portfolio in line with our expectations. With bank lending still constrained and the yield gap between prime and secondary markets still wide, we see opportunities to extend our development and trading activities. Thus, we are seeking to reinvest an element of our equity into further buying opportunities that offer potential for asset enhancement and value creation. These opportunities are not limited to London and the South East.

In October 2013, we acquired a development site in Dublin for €2.4 million. This benefits from an existing planning consent for a mixed-use development that includes twelve luxury apartments, 4,700 sq. ft. of restaurant and retail space, and 6,500 sq. ft. of office accommodation. We expect to be under construction in this quarter having now obtained vacant possession of the site.

In November 2013, we acquired a 64,800 sq. ft. office building in Sevenoaks for £5.5 million at a 5.24 per cent yield. An application for permitted development rights which would allow the building to be converted from office to residential space has subsequently been submitted. The building is well configured for residential use and benefits from its location next to Sevenoaks station, within a strengthening residential market.

In December 2013, we also exchanged contracts to acquire a portfolio of five office properties in Zones 1 and 2 in North London for £17.5 million with completion due next month. The offices are income producing and offer redevelopment options in the medium-term and all benefit from close proximity to good transport links. Further details will be advised upon completion.

During the period, we have generated further gains from the final tranche of disposals within the Chrome portfolio. By the year end, the realisation of assets within this portfolio will be materially complete.

In September 2013, we also announced we had secured a significant planning consent at a site north of Norwich in joint venture with Beyond Green Developments. The scheme will be delivered in phases over the next 15 to 20 years and comprise up to 3,520 homes, 16,800 sq. m. of commercial space, up to 8,800 sq. m. of retail space, two primary schools, a hotel and extensive landscaped public space.

Major developments portfolio

In November 2013, we were pleased to announce that we had signed a pre-let agreement with pharmaceuticals company Takeda, for a 42,000 sq. ft. office building on the Cambridge Science Park. Construction of the laboratory and research building will commence next month. Including this first building, we have secured planning consent for a total of 133,000 sq. ft. of office space across three buildings. Pre-let interest in the remaining two buildings is strong.

In London, our activities are focussed on fringe locations of London's core office market where demand is increasing, with projects in Southwark and Hammersmith. We have recommenced the marketing of the top three floors at 10 Hammersmith Grove after we ended our negotiations with the party who had them under offer. 28 per cent of space is now under offer at 10 Hammersmith Grove. We are now introducing 12 Hammersmith Grove, the next phase of this development comprising 165,000 sq. ft. of office space, to the funding market so that a start on site can be made by the middle of 2014.

At our development site adjacent to Southwark tube station, Algarve House, we are progressing the masterplan for the project with the aim of submitting a planning application for an office-led redevelopment in the second half of this year.

Investment portfolio

We are seeing improving investor appetite in secondary markets outside of London.

In October 2013, we sold the Phones 4u Arena in Manchester for £82.1 million. After finalising our promote entitlements with our joint venture partner, Patron Capital, the sale generated in excess of £10 million of cash to Development Securities and realised a profit ahead of our original expectations.

In November 2013, we sold an industrial trading estate in Brentford, West London, for £13.5 million, a price slightly ahead of its book value.

Across our investment portfolio, we have maintained a good level of lettings in the period with voids rates largely unchanged.

Finance

We maintain a conservative level of gearing as guided by our core principles.

 

For further information, please contact:

Marcus Shepherd/ Michael Marx/Lucy Grimble

020 7828 4777

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGRGDBGDBBGSL
Date   Source Headline
2nd Nov 20213:25 pmRNSForm 8.3 - U AND I GROUP PLC
2nd Nov 20213:20 pmRNSForm 8.3 - U and I Group plc
2nd Nov 20212:30 pmRNSForm 8.3 - U and I Group plc
2nd Nov 20212:19 pmRNSForm 8.3 - U and I Group plc
2nd Nov 20211:55 pmGNWDimensional Fund Advisors Ltd. : Form 8.3 - U AND I GROUP PLC - Ordinary Shares
2nd Nov 20211:04 pmPRNForm 8.3 - U and I Group Plc
2nd Nov 202112:00 pmRNSForm 8.5 (EPT/RI) - U and I Group Plc
2nd Nov 202111:23 amPRNForm 8.3 - U & I Group plc
2nd Nov 202111:21 amRNSForm 8.5 (EPT/RI) - U and I Group plc
2nd Nov 202110:40 amRNSForm 8.3 - U AND I Group Plc
2nd Nov 20219:52 amRNSForm 8.5 (EPT/RI)
2nd Nov 20219:45 amRNSForm 8.3 - U and I Group Plc
1st Nov 202111:53 amRNSRule 2.9 Announcement
1st Nov 20217:00 amRNSRecommended cash offer for U and I Group PLC
1st Oct 202112:02 pmRNSDirector/PDMR Shareholding
9th Sep 20213:56 pmRNSResult of AGM
8th Sep 20217:00 amRNSMorden Wharf planning decision
26th Jul 20218:00 amRNSDirector/PDMR Shareholding
20th Jul 202111:15 amRNSHolding(s) in Company
8th Jul 20217:30 amRNSHolding(s) in Company
1st Jul 202111:44 amRNSDirector/PDMR Shareholding
30th Jun 20212:57 pmRNSDirector/PDMR Shareholding
29th Jun 20214:49 pmRNSDirector/PDMR Shareholding
23rd Jun 20214:20 pmRNS8 Albert Embankment planning decision
18th Jun 20217:01 amRNSAnnual Financial Report and Notice of AGM
9th Jun 20213:27 pmRNSDirector/PDMR Shareholding
2nd Jun 20217:00 amRNSDirector/PDMR Shareholding
26th May 20217:07 amRNSResults for the year ended 31 March 2021
26th May 20217:00 amRNSBoard Changes
11th May 20217:00 amRNSAppointment of CFO
14th Apr 20214:35 pmRNSPrice Monitoring Extension
31st Mar 20214:51 pmRNSDirector/PDMR Shareholding
31st Mar 20214:20 pmRNSDirector/PDMR Shareholding
10th Feb 20215:06 pmRNSDirector/PDMR Shareholding
27th Jan 20217:30 amRNSDirector/PDMR Shareholding
26th Jan 202110:45 amRNSDirector/PDMR Shareholding
25th Jan 20212:54 pmRNSHolding(s) in Company
25th Jan 20212:38 pmRNSDirector/PDMR Shareholding
21st Jan 20214:29 pmRNSDirector/PDMR Shareholding
19th Jan 20217:01 amRNSInterim Results
19th Jan 20217:00 amRNSDirectorate Changes
5th Jan 202111:06 amRNSDirector/PDMR Shareholding
4th Jan 202110:23 amRNSBlock listing Interim Review
27th Nov 20204:40 pmRNSSecond Price Monitoring Extn
27th Nov 20204:36 pmRNSPrice Monitoring Extension
16th Nov 20207:00 amRNSNotice of Interim Results
30th Sep 20203:02 pmRNSDirector/PDMR Shareholding
24th Sep 20207:00 amRNSPositive planning decision in Tunbridge Wells
18th Sep 20207:00 amRNSNew joint venture partnership
10th Sep 20201:43 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.